Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Diabetes Obes Metab ; 26(8): 3110-3118, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38699781

RESUMEN

AIM: Gestational diabetes (GD) is a global health concern with significant implications for maternal and neonatal outcomes. This study investigates the association between early GD (eGD) diagnosis (<24 weeks), pharmacotherapy requirements and adverse neonatal outcomes. MATERIALS AND METHODS: A cohort of 369 pregnant women underwent a 75-g oral glucose tolerance test. Maternal variables, pharmacotherapy prescriptions and neonatal outcomes were analysed employing t-tests, χ2 tests, and logistic regression. A p < .05 was considered significant. RESULTS: Early GD increased the odds of neonatal hypoglycaemia [odds ratio (OR): 18.57, p = .013] and respiratory distress syndrome (OR: 4.75, p = .034). Nutritional therapy prescription by an accredited nutritionist was the most common treatment in women diagnosed after 24 weeks, but those with eGD required more frequently specialized nutritional consulting + metformin to achieve glycaemic control (p = .027). eGD was associated with a higher requirement of nutritional therapy prescription + metformin (OR: 2.26, 95% confidence interval: 1.25-4.09, p = .007) and with maternal hyperglycaemia during the post-partum period at 2 h of the oral glucose tolerance test (OR: 1.03, 95% confidence interval: 1.02-1.13, p = .024). CONCLUSION: Timely diagnosis and personalized treatment of GD are desirable because an earlier presentation is related to a higher risk of adverse neonatal and maternal outcomes.


Asunto(s)
Diabetes Gestacional , Diagnóstico Precoz , Prueba de Tolerancia a la Glucosa , Hipoglucemiantes , Metformina , Humanos , Femenino , Embarazo , Diabetes Gestacional/tratamiento farmacológico , Diabetes Gestacional/diagnóstico , Diabetes Gestacional/sangre , Recién Nacido , Adulto , Hipoglucemiantes/uso terapéutico , Metformina/uso terapéutico , Hipoglucemia/inducido químicamente , Hipoglucemia/prevención & control , Hipoglucemia/epidemiología , Resultado del Embarazo/epidemiología , Estudios de Cohortes , Síndrome de Dificultad Respiratoria del Recién Nacido/prevención & control , Síndrome de Dificultad Respiratoria del Recién Nacido/epidemiología , Glucemia/metabolismo , Glucemia/análisis
2.
Cureus ; 16(2): e54532, 2024 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-38516470

RESUMEN

Gastrointestinal stromal tumors (GISTs) represent a rare form of gastrointestinal neoplasm. This report details a medical case involving a 44-year-old woman who underwent bilateral pheochromocytoma resection, GIST gastrectomy, and laparoscopic adrenalectomy with intestinal resection. Despite an initially positive response to oral imatinib, treatment was delayed due to economic constraints. This delay resulted in a critical event marked by abdominal GIST metastasis to the abdominal wall, subsequent rupture leading to hemoperitoneum, and emergency surgery. Following an adequate postsurgical recovery, she was successfully discharged prior to medication adjustments.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...